KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Retained Earnings (2016 - 2025)

Abbott Laboratories' Retained Earnings history spans 17 years, with the latest figure at $49.8 billion for Q4 2025.

  • For Q4 2025, Retained Earnings rose 729.66% year-over-year to $49.8 billion; the TTM value through Dec 2025 reached $49.8 billion, up 729.66%, while the annual FY2025 figure was $49.8 billion, 729.66% up from the prior year.
  • Retained Earnings for Q4 2025 was $49.8 billion at Abbott Laboratories, up from -$6.7 billion in the prior quarter.
  • Across five years, Retained Earnings topped out at $49.8 billion in Q4 2025 and bottomed at -$9.2 billion in Q3 2021.
  • The 5-year median for Retained Earnings is $28.9 billion (2021), against an average of $16.8 billion.
  • The largest annual shift saw Retained Earnings tumbled 130.31% in 2021 before it skyrocketed 729.66% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$8.4 billion in 2021, then skyrocketed by 521.03% to $35.3 billion in 2022, then crashed by 122.23% to -$7.8 billion in 2023, then dropped by 0.85% to -$7.9 billion in 2024, then surged by 729.66% to $49.8 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Retained Earnings are $49.8 billion (Q4 2025), -$6.7 billion (Q3 2025), and $48.5 billion (Q2 2025).